Production (Stage)
Devonian Health Group Inc.
DVHGF
$0.18
$0.036225.17%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.43% | 256.11% | 344.33% | 727.46% | 1,235.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.43% | 256.11% | 344.33% | 727.46% | 1,235.12% |
| Cost of Revenue | 15.03% | 293.10% | 444.86% | 823.04% | 1,356.48% |
| Gross Profit | 65.21% | 190.98% | 220.34% | 606.57% | 1,006.07% |
| SG&A Expenses | 30.01% | 0.71% | 134.82% | 77.31% | 40.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 0.00% | -1.31% | 1.31% | 1.87% | 4.27% |
| Total Operating Expenses | 23.49% | 133.18% | 230.90% | 312.65% | 209.49% |
| Operating Income | 89.85% | 120.18% | 11.66% | 248.06% | 80.23% |
| Income Before Tax | -1,126.72% | 116.43% | 16.37% | 221.99% | 74.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -610.75% | 82.12% | 16.37% | 221.99% | 56.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -610.75% | 82.12% | 16.37% | 221.99% | 56.66% |
| EBIT | 89.85% | 120.18% | 11.66% | 248.06% | 80.23% |
| EBITDA | 131.55% | 130.47% | 10.65% | 307.87% | 86.67% |
| EPS Basic | -612.50% | 81.97% | 16.67% | 220.45% | 61.45% |
| Normalized Basic EPS | 108.33% | 115.79% | 17.39% | 222.22% | 76.92% |
| EPS Diluted | -612.50% | 85.14% | 18.92% | 220.45% | 61.45% |
| Normalized Diluted EPS | 109.09% | 115.79% | 17.39% | 222.22% | 78.85% |
| Average Basic Shares Outstanding | 0.47% | 1.28% | 1.55% | 0.57% | 12.09% |
| Average Diluted Shares Outstanding | -0.73% | 1.28% | 1.55% | 0.57% | 22.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |